Published in Immunol Cell Biol on August 01, 1995
The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A (2005) 4.12
Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol (2003) 2.14
Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci U S A (2003) 2.09
Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol (2010) 1.83
Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol (2010) 1.67
Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant (2014) 1.63
Qualitative differences between naïve and memory T cells. Immunology (2002) 1.48
Suppression of the stem cell antigen-1 response and granulocyte lineage expansion by alcohol during septicemia. Crit Care Med (2011) 1.46
Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands. Protein Sci (2006) 1.33
SLEEPLESS, a Ly-6/neurotoxin family member, regulates the levels, localization and activity of Shaker. Nat Neurosci (2009) 1.27
Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci (1999) 1.23
Myeloid-derived suppressor cells in transplantation and cancer. Immunol Res (2012) 1.23
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology (2010) 1.18
The major locus for mouse adenovirus susceptibility maps to genes of the hematopoietic cell surface-expressed LY6 family. J Immunol (2010) 1.15
Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J (2006) 1.11
The Caenorhabditis elegans odr-2 gene encodes a novel Ly-6-related protein required for olfaction. Genetics (2001) 1.10
Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons. J Neurosci (2009) 1.08
Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res (2012) 1.06
Isolation of a neurotoxin (alpha-colubritoxin) from a nonvenomous colubrid: evidence for early origin of venom in snakes. J Mol Evol (2003) 0.99
Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1. J Virol (2005) 0.95
Proteome analysis of round-headed and normal spermatozoa by 2-D fluorescence difference gel electrophoresis and mass spectrometry. Asian J Androl (2009) 0.91
Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6. Eur Neuropsychopharmacol (2009) 0.90
Toll-like receptor 4/stem cell antigen 1 signaling promotes hematopoietic precursor cell commitment to granulocyte development during the granulopoietic response to Escherichia coli bacteremia. Infect Immun (2013) 0.89
Alcohol impairs the myeloid proliferative response to bacteremia in mice by inhibiting the stem cell antigen-1/ERK pathway. J Immunol (2012) 0.87
On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni. PLoS Negl Trop Dis (2013) 0.85
Prostate stem cell antigen rs2294008 polymorphism differentially contributes to Helicobacter pylori-negative gastric cancer among various populations in China. Mol Clin Oncol (2013) 0.85
IFATS collection: Stem cell antigen-1-positive ear mesenchymal stem cells display enhanced adipogenic potential. Stem Cells (2008) 0.84
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study. BMC Res Notes (2012) 0.83
Inhibition of the function of the FcgammaRIIB by a monoclonal antibody to thymic shared antigen-1, a Ly-6 family antigen. Immunology (2001) 0.82
Characterization and function of human Ly-6/uPAR molecules. BMB Rep (2012) 0.81
Organization, evolution and functions of the human and mouse Ly6/uPAR family genes. Hum Genomics (2016) 0.79
Identification and expression of a novel member of Ly-6 superfamily in zebrafish Denio rerio. Dev Genes Evol (2012) 0.78
Isolation, characterization, and transplantation of cardiac endothelial cells. Biomed Res Int (2013) 0.78
Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer. Immunology (1997) 0.78
Sca-1 is involved in the adhesion of myosphere cells to αVβ3 integrin. Biol Open (2012) 0.77
Identification and expression of an uncharacterized Ly-6 gene cluster in zebrafish Danio rerio. Funct Integr Genomics (2015) 0.77
Identification and structural characterization of a new three-finger toxin hemachatoxin from Hemachatus haemachatus venom. PLoS One (2012) 0.76
Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance. Cancer Res (2016) 0.76
Impact of Toxoplasma gondii on Dendritic Cell Subset Function in the Intestinal Mucosa. J Immunol (2015) 0.76
The prototoxin LYPD6B modulates heteromeric α3β4-containing nicotinic acetylcholine receptors, but not α7 homomers. FASEB J (2015) 0.76
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis. Oncotarget (2016) 0.75
Impairment of Hematopoietic Precursor Cell Activation during the Granulopoietic Response to Bacteremia in Mice with Chronic-Plus-Binge Alcohol Administration. Infect Immun (2017) 0.75
Identification of a Ly-6 superfamily gene expressed in lateral line neuromasts in zebrafish. Dev Genes Evol (2015) 0.75
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol (1983) 1.86
A high proportion of hybridomas raised to a plant extract secrete antibody to arabinose or galactose. Plant Physiol (1984) 1.84
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII. Transplantation (2000) 1.46
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet (1968) 1.35
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens (2006) 1.32
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol (1993) 1.32
Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Proc Natl Acad Sci U S A (1973) 1.30
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol (1999) 1.29
Role of the mannose receptor in the immune response. Curr Mol Med (2001) 1.28
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med (1995) 1.28
Identification and quantification of complement regulator CD46 on normal human tissues. Immunology (1993) 1.28
Antibody production in immunosuppressed recipients of renal allografts. Lancet (1969) 1.28
Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen. Cell Immunol (1976) 1.26
Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol (1989) 1.23
Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust J Exp Biol Med Sci (1980) 1.22
Hu Ly-m5: a unique antigen physically associated with HLA molecules. Hum Immunol (1983) 1.22
A genomic clone encoding the alpha chain of the OKM1, LFA-1, and platelet glycoprotein IIb-IIIa molecules. Proc Natl Acad Sci U S A (1986) 1.20
Mutation in the IA subregion of the murine H-2 complex. Immunogenetics (1980) 1.20
A new breast carcinoma antigen defined by a monoclonal antibody. J Natl Cancer Inst (1985) 1.20
Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. Transpl Immunol (1993) 1.19
Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19
Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation (1995) 1.17
The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci U S A (1986) 1.17
Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer (1994) 1.16
A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst (1983) 1.16
Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci U S A (1995) 1.16
Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1. J Immunol (1980) 1.15
Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. J Immunol (1990) 1.14
The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. Immunogenetics (1987) 1.13
Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine (1996) 1.11
Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails. J Gen Virol (1994) 1.10
MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunol Immunother (2000) 1.10
Variations in the responses of C57BL-10J and A-J mice to sheep red blood cells. J Exp Med (1972) 1.08
Major histocompatibility gene complex (MHC)-coded determinants on antigen-specific suppressor factor for delayed-type hypersensitivity and surface phenotypes of cells producing the factor. Eur J Immunol (1980) 1.08
Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J Immunol (1997) 1.08
Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex. J Exp Med (1973) 1.08
Cellular mucins: targets for immunotherapy. Crit Rev Immunol (1994) 1.08
Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis. Int J Cancer (1999) 1.08
Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal. Proc Natl Acad Sci U S A (1997) 1.08
Lesions in the vasa recta in experimental analgesic nephropathy. Lancet (1968) 1.07
Cytotoxic T-cell response to Ectromelia virus-infected cells. Different H-2 requirements for triggering precursor T-cell induction or lysis by effector T cells defined by the BALB/c-H-2db mutation. J Exp Med (1977) 1.06
Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3. Hum Immunol (1983) 1.06
Detection of mouse alloantibodies by rosetting with protein A-coated sheep red blood cells. Transplantation (1978) 1.05
Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics (1991) 1.04
Recent advances in xenotransplantation. Curr Opin Immunol (1999) 1.04
Studies of methotrexate-monoclonal antibody conjugates for immunotherapy. J Natl Cancer Inst (1985) 1.04
Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse. J Immunol (1983) 1.04
Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection. Transplantation (1982) 1.04
Expression of the high responder/non-responder human Fc gamma RII. Analysis by PCR and transfection into FcR-COS cells. Immunol Cell Biol (1992) 1.03
The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res (1991) 1.03
Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies. J Immunol (1975) 1.03
Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J Biol Chem (1994) 1.02
Serological analysis of antigen-specific helper factors specific for poly-L(Tyr, Glu)-poly-DLAla--poly-LLys [(T, G)-A--L] and L Glu60-LAla30-LTyr10 (GAT). Eur J Immunol (1979) 1.02
Chimeric Fc receptors identify functional domains of the murine high affinity receptor for IgG. J Immunol (1991) 1.02
Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur J Immunol (2000) 1.01
Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine (2000) 1.01
A comparison of the cytolytic action of guinea pig and rabbit complement on sensitized nucleated mouse cells. J Immunol (1973) 0.99
Immunological enhancement of skin grafts in the mouse. J Immunol (1972) 0.99
Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection. Transplantation (1982) 0.99